A scarcity of some medicines is placing sufferers in danger, pharmacists have warned.
A ballot of 1,562 UK pharmacists for the Pharmaceutical Journal discovered greater than half (54%) believed sufferers had been put in danger up to now six months as a result of shortages.
Quite a lot of sufferers have been dealing with difficulties accessing some medicines in latest months, generally having to go to a number of pharmacies to search out their prescription or needing to return to their GP to be prescribed an alternate.
The drawback got here to the fore when shortages of hormone alternative remedy medicine led to an outcry earlier this yr.
Since June, the federal government has issued plenty of “medicine supply notifications”, which spotlight shortages.
Some of those embody: ache aid medicine utilized in childbirth; mouth ulcer remedy; migraine therapy; an antihistamine; a drug utilized by prostate most cancers and endomitosis sufferers; an antipsychotic drug used amongst bipolar dysfunction and schizophrenia sufferers; a kind of inhaler and a sure model of insulin.
The Pharmaceutical Journal additionally reported that on 3 August, ministers urged hospitals to “conserve stock” of an anti-clotting drug used to deal with strokes.
Some pharmacists have expressed issues about switching sufferers on sure remedy to options.
Ways to ease scarcity
Community pharmacists advised the Pharmaceutical Journal on this month that shortages of the osteoporosis medication alendronic acid have been contributing to remedy errors when options have been prescribed.
The journal reported talks have begun with pharmacy leaders and the federal government about methods to ease the shortages.
Explainer: Why is there a scarcity of HRT?
A pharmacist at a youngsters’s hospital in England mentioned issues with variable provide of dietary merchandise was placing sufferers in danger.
“We had to ration it, and this has potentially put patients at risk of vitamin deficiencies,” she mentioned.
Another hospital pharmacist raised issues about medicine being unavailable on the finish of a affected person’s life.
They advised the journal: “There was no alternative for one patient who had to deal with an additional symptom in his last days of life due to lack of available treatment.”
Patient security
Mike Dent, director of pharmacy funding on the Pharmaceutical Services Negotiating Committee, advised the journal: “We are becoming increasingly concerned about medicine supply issues and the very serious impact this is having on both community pharmacy teams and their patients.”
A Department of Health and Social Care spokesperson mentioned: “We take patient safety extremely seriously, and we routinely share information about medicine supply issues directly with the NHS so they can put plans in place to reduce the risk of any shortage impacting patients, including offering alternative medication.
“We have well-established procedures to cope with medication shortages and work carefully with trade, the NHS and others to forestall shortages and resolve any points as quickly as potential.”
Source: information.sky.com”